Central Nervous System Embryonal Tumor — Trials

Central Nervous System Embryonal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

240 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 72
Recruiting: 33
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–50 of 240 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07492316	RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)(PNOC020 rMB)	active not recruiting	Phase 1	24	University of FloridaOTHER	1	Sep 29, 2026	clinicaltrials
NCT01445288	Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors	completed	—	76	National Cancer Institute (NCI)NIH	1	Sep 28, 2026